Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain
Chronic Low-back Pain
About this trial
This is an interventional treatment trial for Chronic Low-back Pain focused on measuring chronic low back pain
Eligibility Criteria
Inclusion Criteria:
- significant daily chronic pain intensity (≥4 on a 10-point scale) and interference in performing daily activities due to pain (≥3 on a 10-point scale) for at least 3 months
- age 18-75 years (inclusive)
- not using opioid analgesics on a daily basis or within 3 days of each laboratory session (confirmed via urine drug screen)
- Intact cognitive status and ability to provide informed consent
- ability to read and write in English sufficiently to understand and complete study questionnaires
Exclusion Criteria:
- meet criteria for alcohol or substance abuse problems
- meet criteria for past or present psychotic or bipolar disorders
- inability to understand English well enough to complete questionnaires or participate in therapy
- pain due to malignant conditions, rheumatoid arthritis, migraine or tension headache, complex regional pain syndrome, or fibromyalgia syndrome
- lumbar surgery within past 6 months
- pregnant
- signs of nerve root compression (ie, positive straight-leg raise <45○).
- liver diseases (e.g hepatitis or cirrhosis)
- suicide ideation with intent
- osteoporosis or bone demineralization
- opioid-dependency
- inability to hold breathe for 15 seconds
- acute trauma to spine
- long term use of corticosteroids
- spinal cord stimulator or IT pump inserted in back
- they have a BMI equal to or above 40
Sites / Locations
- Rush University Medical CenterRecruiting
- Vanderbilt University Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
SMT plus placebo/naloxone
MT plus placebo/naloxone
Participants are randomly assigned to an 8 week SMT treatment group conducted by certified physical therapists. Immediately before and after the treatment sessions along with midway through the treatment (after 4 sessions), participants will undergo the placebo/naloxone administration intervention to assess mechanisms of SMT or MT-related changes.
Participants are randomly assigned to an 8 week MT treatment group conducted by certified clinical therapists. Immediately before and after the treatment sessions along with midway through the treatment (after 4 sessions), participants will undergo the placebo/naloxone administration intervention to assess mechanisms of SMT or MT-related changes.